187 related articles for article (PubMed ID: 21126200)
1. Inhibition of atrogin-1/MAFbx expression by adenovirus-delivered small hairpin RNAs attenuates muscle atrophy in fasting mice.
Cong H; Sun L; Liu C; Tien P
Hum Gene Ther; 2011 Mar; 22(3):313-24. PubMed ID: 21126200
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.
Lagirand-Cantaloube J; Cornille K; Csibi A; Batonnet-Pichon S; Leibovitch MP; Leibovitch SA
PLoS One; 2009; 4(3):e4973. PubMed ID: 19319192
[TBL] [Abstract][Full Text] [Related]
3. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
4. Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone.
Zhao W; Pan J; Wang X; Wu Y; Bauman WA; Cardozo CP
Endocrinology; 2008 Nov; 149(11):5449-60. PubMed ID: 18599544
[TBL] [Abstract][Full Text] [Related]
5. Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting.
Lokireddy S; Wijesoma IW; Sze SK; McFarlane C; Kambadur R; Sharma M
Am J Physiol Cell Physiol; 2012 Sep; 303(5):C512-29. PubMed ID: 22673621
[TBL] [Abstract][Full Text] [Related]
6. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
8. Flavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes.
Shiota C; Abe T; Kawai N; Ohno A; Teshima-Kondo S; Mori H; Terao J; Tanaka E; Nikawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):188-94. PubMed ID: 26052151
[TBL] [Abstract][Full Text] [Related]
9. Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes.
Dehoux M; Van Beneden R; Pasko N; Lause P; Verniers J; Underwood L; Ketelslegers JM; Thissen JP
Endocrinology; 2004 Nov; 145(11):4806-12. PubMed ID: 15284206
[TBL] [Abstract][Full Text] [Related]
10. Identification of essential sequences for cellular localization in the muscle-specific ubiquitin E3 ligase MAFbx/Atrogin 1.
Julie LC; Sabrina BP; Marie-Pierre L; Leibovitch SA
FEBS Lett; 2012 Feb; 586(4):362-7. PubMed ID: 22249105
[TBL] [Abstract][Full Text] [Related]
11. Effect of dexamethasone on the expression of atrogin-1/MAFbx in chick skeletal muscle.
Nakashima K; Ishida A; Ijiri D; Ohtsuka A
Anim Sci J; 2016 Mar; 87(3):405-10. PubMed ID: 26279163
[TBL] [Abstract][Full Text] [Related]
12. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
Jin B; Li YP
J Cell Biochem; 2007 Mar; 100(4):960-9. PubMed ID: 17131360
[TBL] [Abstract][Full Text] [Related]
13. Decreased muscle atrophy F-box (MAFbx) expression in regenerating muscle after muscle-damaging exercise.
Okada A; Ono Y; Nagatomi R; Kishimoto KN; Itoi E
Muscle Nerve; 2008 Oct; 38(4):1246-53. PubMed ID: 18785187
[TBL] [Abstract][Full Text] [Related]
14. Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase.
Tintignac LA; Lagirand J; Batonnet S; Sirri V; Leibovitch MP; Leibovitch SA
J Biol Chem; 2005 Jan; 280(4):2847-56. PubMed ID: 15531760
[TBL] [Abstract][Full Text] [Related]
15. Joint inflammation alters gene and protein expression and leads to atrophy in the tibialis anterior muscle in rats.
RamÃrez C; Russo TL; Sandoval MC; Dentillo AA; Couto MA; Durigan JL; Salvini TF
Am J Phys Med Rehabil; 2011 Nov; 90(11):930-9. PubMed ID: 21959222
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.
Bodine SC; Baehr LM
Am J Physiol Endocrinol Metab; 2014 Sep; 307(6):E469-84. PubMed ID: 25096180
[TBL] [Abstract][Full Text] [Related]
17. The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
Lagirand-Cantaloube J; Offner N; Csibi A; Leibovitch MP; Batonnet-Pichon S; Tintignac LA; Segura CT; Leibovitch SA
EMBO J; 2008 Apr; 27(8):1266-76. PubMed ID: 18354498
[TBL] [Abstract][Full Text] [Related]
18. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
Sandri M; Sandri C; Gilbert A; Skurk C; Calabria E; Picard A; Walsh K; Schiaffino S; Lecker SH; Goldberg AL
Cell; 2004 Apr; 117(3):399-412. PubMed ID: 15109499
[TBL] [Abstract][Full Text] [Related]
19. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
[TBL] [Abstract][Full Text] [Related]
20. Structure and function of the upstream promotor of the human Mafbx gene: the proximal upstream promotor modulates tissue-specificity.
Zhao W; Wu Y; Zhao J; Guo S; Bauman WA; Cardozo CP
J Cell Biochem; 2005 Sep; 96(1):209-19. PubMed ID: 16052482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]